Home
Conditions
Digestive System Neoplasms

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,203 public trials 3,225 recruiting studies

Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

NCT01171300

Conditions: Adenocarcinoma, Carcinoma, Colorectal Neoplasms, +12 more
Locations: University Hospitals Gasthuisberg Leuven, Vlaams-Brabant, Belgium

View Trial Details

Active, Not Recruiting

PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer

NCT04715633

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: 651 Dongfeng Road East Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Direct Information to At-risk Relatives

NCT04197856

Conditions: Adnexal Diseases, Breast Cancer, Familial, Breast Diseases, +37 more
Locations: Cancergenetisk mottagning Umeå, Sweden

View Trial Details

Active, Not Recruiting

Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients

NCT03760822

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +9 more
Locations: CH - Abbeville, France

CH - Albi Albi, France

PRIVEE - L'Europe Amiens, France

CAC - ICO Site Paul Papin Angers, France

View all 38 locations

View Trial Details

Active, Not Recruiting

Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC

NCT06490107

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Active, Not Recruiting

Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma

NCT03959293

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
Locations: Ch - Centre Hospitalier Abbeville, France

Ch - Hôpital Claude Bernard Albi, France

Chu - Hôpital Sud Amiens, France

Privé - Clinique de L'Europe Amiens, France

View all 35 locations

View Trial Details

Active, Not Recruiting

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

NCT06138769

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma

NCT03306901

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations: National Cancer Center Goyang-si, South Korea

Pusan National University Hospital Pusan, South Korea

Seoul National University Bundang Hospital Seongnam, South Korea

Asan Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG

NCT04878783

Conditions: Adenocarcinoma of the Stomach, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: University of Padova Padova, Italy

Link Campus University Roma, Italy

Giovanni Maria Garbarino Roma, Italy

University of Verona Verona, Italy

View Trial Details

Active, Not Recruiting

Two Chemotherapy Regimens Plus or Minus Bevacizumab

NCT03351296

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Centre Antoine Lacassagne Nice, Alpes-Maritimes, France

CHU de Caen Caen, Calvados, France

CHU de Dijon Dijon, Côte d'Or, France

Hôpital Haut-Lévêque Pessac, Gironde, France

View all 20 locations

View Trial Details

Digestive System Neoplasms

Digestive System Neoplasms trial results

Related conditions